Search

everythinglearnresearchcommunity

for

Search:↓

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

Low iron levels are strongly linked to chronic hair loss in women.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Propionibacterium acnes might be linked to hair casts and possibly alopecia.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Dermoscopes help tell FPHL apart from other hair loss types and can detect it early by identifying specific patterns.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Dermatologists prefer minoxidil for mild female hair loss and a combination of PRP and minoxidil for severe cases, with a need for universal treatment guidelines.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Finasteride improves hair loss in women with hyperandrogenism.

Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.